ARIDIS PHARMACEU(ARDS) - 2022 Q4 - Annual Report
ARIDIS PHARMACEUARIDIS PHARMACEU(US:ARDS)2023-05-22 21:22

Washington, D.C. 20549 FORM 10-K (Mark one) UNITED STATES SECURITIES AND EXCHANGE COMMISSION ☒ Annual Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 For the fiscal year ended December 31, 2022 Or ☐ Transition Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 For the transition period from to Commission file number 001-38630 Aridis Pharmaceuticals, Inc. (Exact name of Registrant as specified in its charter) Delaware 47-2641188 (State or other jurisdi ...